9 results
10-K
2022 FY
COYA
Coya Therapeutics Inc
29 Mar 23
Annual report
4:08pm
remedies against fraud and abuse, add new transparency requirements for the healthcare and health insurance industries, impose new taxes and fees … Congressional inquiries and proposed and enacted bills designed to, among other things,
bring more transparency to product pricing, review the relationship
424B4
COYA
Coya Therapeutics Inc
30 Dec 22
Prospectus supplement with pricing info
4:17pm
and transparency measures. We believe that coverage and reimbursement for new therapies will be increasingly restricted. Recent U.S. Congressional inquiries … and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to drug pricing, review the relationship
S-1/A
COYA
Coya Therapeutics Inc
5 Dec 22
IPO registration (amended)
8:16am
treatments, patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures. We … and enacted federal and state legislation designed to, among other things, bring more transparency to drug pricing, review the relationship between pricing
S-1
1dujlsu10yjtjvp
18 Nov 22
IPO registration
5:06pm
DRS/A
wc0oo
28 Oct 22
Draft registration statement (amended)
12:00am
DRS/A
w3m0cevo
7 Oct 22
Draft registration statement (amended)
12:00am
DRS
3rn 6s2yvdpkj
19 Aug 22
Draft registration statement
12:00am
- Prev
- 1
- Next